For COVID-19 and vaccination updates, view our information for the community. If you're experiencing symptoms, call your primary care provider.
A Randomized Phase III, Two-Arm Trial of Paclitaxel/Carboplatin/Maintenance Letrozole versus Letrozole Monotherapy in Patients with Stage II-IV, Primary Low-Grade Serous Carcinoma of the Ovary or Peritoneum
To determine how well the oral drug Letrozole works with or without Paclitaxel and Carboplatin in treating stage II-IV low grade cancer of the ovary or peritoneum.
DiagnosisStage II-IV low grade serous carcinoma of the ovary or peritoneum.
Must have had surgery within 8 weeks prior to starting chemotherapy.
Patients must sign an approved informed consent and authorization permitting release of personal health information.
- Group 1: You will get Paclitaxel, Carboplatin and Letrozole
- Group 2: You will get Letrozole
For more information, visit ClinicalTrials.gov